Indications
Therapeutic Asset Ratings
18,139 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Lenvatinib
Metastatic Malignant Neoplasm
Salubris Biotherapeutics Inc
P3
B
(63)
Letrozole
Primary Peritoneal Serous Adenocarcinoma
NRG Oncology
P3
B
(63)
Letrozole
Primary Peritoneal Carcinoma
Avenzo Therapeutics, Inc.
P3
B
(63)
Lisaftoclax
Acute Myeloid Leukemia
First Affiliated Hospital of Zhejiang University
P3
B
(63)
Lurbinectedin
Small Cell Carcinoma
SystImmune Inc.
P3
B
(63)
Methotrexate
Down Syndrome
National Cancer Institute (NCI)
P3
B
(63)
Methotrexate
Intraocular Lymphoma
Aldeyra Therapeutics, Inc.
P3
B
(63)
Methotrexate
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
Andrew E. Place, MD
P3
B
(63)
Mifepristone
Major Depressive Disorder
Amsterdam UMC, location VUmc
P3
B
(63)
Mitoxantrone
Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow University
P3
B
(63)
Muamycin
Appendix Carcinoma
City of Hope Medical Center
P3
B
(63)
Multiple Vitamins Injection
Basal Cell Carcinoma
Women's College Hospital
P3
B
(63)
Multiple Vitamins Injection
Squamous Cell Carcinoma
Women's College Hospital
P3
B
(63)
Nepenthe
Cancer-Related Condition
Instituto Nacional de Cancer, Brazil
P3
B
(63)
Neurotop
Tuberous Sclerosis
GRIN Therapeutics, Inc.
P3
B
(63)
Nogitecan
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)
P3
B
(63)
Nogitecan
Ovarian Neoplasm
GlaxoSmithKline
P3
B
(63)
Olaparib
Fallopian Tube Cancer
University of Colorado, Denver
P3
B
(63)
Olaparib
Non-Small Cell Lung Carcinoma
Qilu Pharmaceutical Co., Ltd.
P3
B
(63)
Olaparib
Prostate Neoplasm
Nuvation Bio Inc.
P3
B
(63)
Ondansetron
Hematopoietic And Lymphoid System Neoplasm
Yale University
P3
B
(63)
Orelabrutinib
Mantle Cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.
P3
B
(63)
Osimertinib
Hepatocellular Carcinoma
AstraZeneca
P3
B
(63)
Osimertinib
Lung Cancer
Beijing Pearl Biotechnology Limited Liability Company
P3
B
(63)
Oxaliplatin
Chemotherapy-Induced Toxicity
Linhui Peng
P3
B
(63)
Showing 2801 to 2825 of 18,139 assets
Previous
Page 113 of 726
Next